5
Biosimilars
in
Latin America
Meeting of Latin American Experts to Address the Gap Between National Registries
on Biologics and National Surveillance Agencies Dealing with Biosimilars
Recommendations to Ensure Safety and Effectiveness
of Biosimilars in Latin America: A Point of View
The Americas Health Foundation (AHF) recently planned, organized and convened a meeting of experts from Latin America to address the gaps between National Registries on Biologics and National Surveillance Agencies dealing with biosimilars. The group of experts developed official recommendations concerning how to integrate the data from both organizations. The article, 'Recommendations to ensure safety and effectiveness of biosimilars in Latin America: a point of view' was published online in February 2015 by Clinical Rheumatology and is available through pubmed. Click here to read the full article.
PANELISTS INCLUDED